Evidence of Long-Lasting Humoral and Cellular Immunity against SARS-CoV-2 Even in Elderly COVID-19 Convalescents Showing a Mild to Moderate Disease Progression.

Life (Basel) · 2021 · PMC8401673 · PMID 34440549

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

Treatment with specific SARS-CoV-2 peptides led to a highly significant increased IFN-γ-release (3.93 ± 0.71 IU/mL vs. 0.34 ± 0.10 IU/mL; p < 0.0001) in convalescents compared to unstimulated whole blood.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.